Email this article Experimental study on the expression and diagnostic significance of I-FABP in acute intestinal ischemia
Vol 5, Issue 2.1, 2021
VIEWS - 43 (Abstract)
Abstract
Objective: To detect the expression and distribution of I-FABP in intestinal tissue and the changes of serum concentrations at different time of acute intestinal ischemia, and explore the significance and mechanism of I-FABP in early diagnosis of acute ischemic bowel disease. Methods: The selected 96 healthy adult SD rats were randomly divided into the experimental group and control group; 48 in each group. Each group was randomly subdivided into 6 groups with 8 rats in each group. The superior mesenteric artery was ligated in the experimental group and the peritoneal switch operation was performed in the control group. The venous blood samples were extracted from each group rats’ right ventricle at 0.5 h, 1 h, 2 h, 4 h, 8 h, 12 h after the operation and the concentration of I-FABP was tested respectively. Then the rats were killed, and the diseased intestinal tubes were cut out for paraffin sections. The I-FABP in intestinal tissue was stained by routine HE staining and direct immunofluorescence staining. Results: The I-FABP was mainly expressed in the epithelial villi of intestinal mucosa, and there was a small amount of expression in the intestinal submucosa and even the muscularis. Within 1 hour of intestinal ischemia, the number of I-FABP positive granules in the intestine and intestinal cavity increased gradually, and then gradually decreased after 1 hour. The difference has statistically significant between the experimental group and the control group (P < 0.05). The serum I-FABP: In the experimental group, the serum I-FABP concentration began to increase at 0.5 h, and reached a peak at 1 h (290. 24 ± 156.69) μg·L–1, then gradually decreased. Compared with the control group, the difference was statistically significant (P < 0.05). Conclusion: I-FABP usually mainly exists in the epithelial cells of intestinal mucosa. When acute intestinal ischemia occurs, the epithelial cells of intestinal mucosa permeability changes; I-FABP expression rapidly releases to intestinal tissue and intestinal cavity, and is absorbed into the blood. Therefore, I-FABP has certain clinical significance in early diagnosis and treatment of acute intestinal ischemia.
Keywords
Full Text:
PDFReferences
1. Karaca Y, Gündüz A, Türkmen S, et al. Diagnostic value of procalcitonin levels in acute mesenteric ischemia. Balkan Medical Journal 2015; 32(3): 291–295.
2. Van den Heijkant TC, Aerts BAC, Teijink JA, et al. Challenges in diagnosing mesenteric ischemia. World Journal of Gastroenterology 2013; 19(9): 1338–1341.
3. Zheng L, Feng Z, Wei F. The value of I-FABP measurement in the diagnosis of intestinal ischemic in patients with acute intestinal obstruction. International Journal of Laboratory Medicine 2014; 35(4): 410–411.
4. Hirotada K, Hiroshi A, Hitoshi T, et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. Plos One 2014; 9(6): e99915.
5. Shi H, Wu B. Correlation of serum intestinal fatty acid binding protein and D-lactate with ischemic time and intestinal injury in acute mesenteric ischemia rats. Chinese journal of Multiple Organ Diseases in the Elderly 2013; 12(7): 526–529.
6. Zeng X, Xu Z, Ling X. Early diagnosis of acute ischemic bowel disease progress (in Chinese). Progress of Modern General Surgery in China 2007; 10(5): 438–441.
7. March DS, Marchbank T, Playford RJ, et al. Intestinal fatty acid-binding protein and gut permeability responses to exercise. European Journal of Applied Physiology 2017; 117(5): 931–941.
8. Güzel M, Sözüer EM, Salt O, et al. The value of the serum I-FABP level for diagnosing acute mesenteric. Surgery Today 2014; 44(11): 2072–2076.
9. Van der Voort PHJ, Westra B, Wester JPJ, et al. Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia. BMC Anesthesiology 2014; 14: 111–121.
10. Angela M, Gajda, Storch J. Enterocyte fatty acid-binding proteins (FABPs): Different functions of liver and intestinal FABPs in the intestine. Prostaglandins, Leukotrienes and Essential Fatty Acids 2015; 93: 9–16.
11. Acosta S, Nilsson T. Current status on plasma biomarkers for acute mesenteric ischemia. Thromb Thrombolysis 2012; 33: 355–361.
12. Loor JJ, Yudell BE, Nakamura TM. Regulation of energy metabolism by long-chain fatty acids. Progress in Lipid Research 2014; 53: 124–144.
13. Salim SY, Young PY, Churchill TA, et al. Urine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients. Journal of Surgical Research 2017; 209: 258–265.
14. Powell A, Armstrong P. Plasma biomarkers for early diagnosis of acute intestinal ischemia. Seminars in Vascular Surgery 2014; 27(3-4): 170–175.
15. Venkatachalam AB, Sawler DL, Wright JM. Tissue-specific transcriptional modulation of fatty acid-binding protein genes, fabp2, fabp3 and fabp6, by fatty acids and the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio). Gene 2013; 520(1): 14–21.
16. Venkatachalam AB, Lall SP, Denovan-Wright EM, et al. Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio). BMC Evolutionary Biology 2012; 12: 112–126.
DOI: https://doi.org/10.24294/ti.v5.i2.1.1373
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Haikun Li, Minhua Wang, Xiansen Zhu, Xiaoqing Zhou, Bin Yang, Qinghui Yin, Xiaoping Liu, Xiangfu Zeng, Yan Hu, Xiangtai Zeng
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This site is licensed under a Creative Commons Attribution 4.0 International License.